Kolaviron Improved Resistance to Oxidative Stress and Inflammation in the Blood (Erythrocyte, Serum, and Plasma) of Streptozotocin-Induced Diabetic Rats

Table 3

Effects of kolaviron treatment on levels of inflammatory proteins and growth factor.

	IL-1𝛽 (pg/mL)	MCP-1 (pg/mL)	VEGF (pg/mL)
NC	28.37±10.54	226.62±75.71	10.45±1.4
KV	20.48±5.13	231.26±78.31	9.49±2.5
DM	43.32±8.65^a	542.77±67.27^a	15.41±1.96^a
DM + KV	16.43±7.74^b	266.61±81.36^b	12.44±1.73^b

Table 3 shows effects of kolaviron on interleukin (IL)-1𝛽, monocyte chemotactic protein (MCP-1), and vascular endothelial growth factor (VEGF). Data are presented as mean ± S.D. ^aValues differ significantly from normal control (𝑃<0.05). ^bValues differ significantly from diabetic control (𝑃<0.05). NC: normal control; KV: normal control treated with kolaviron; DM: untreated diabetic rats; DM + KV: diabetic rats treated with kolaviron.